Therefore, it remains difficult to distinguish whether increased serum adiponectin by itself might be a true risk factor that is intimately involved in the development of AAC, or simply a surrogate marker of renal dysfunction. This evidence concerns the gene ADIPOQ and Abnormal renal physiology.